Bristol-Myers Squibb Co.

Links: Y! CELG MM R&D deep dive BMY Roulette

BMY / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
668	CELG CVR Investor Survey Results (n=75) ... BMY Management, Take Note	GN	lumpygravy		11	9/18/2019 8:13:06 AM

667	What Is Atrial Fibrillation (AFib) and How Can It Lead to Stroke?	GN	Biotech2050		1	9/17/2019 12:03:46 PM

666	What to watch for at the ESMO Conference	GN	lumpygravy		6	9/17/2019 8:24:40 AM

665	Cowen and Morgan Stanley price targets on CELG partner XLRN	GN	Biotech2050		0	9/17/2019 3:40:28 AM

664	Endpoints article: Acceleron drops a development program as #2 drug fails to spark functional benefits in patients with a rare neuromuscular ailment	GN	Biotech2050		1	9/16/2019 11:43:55 PM

663	Fiercebiotech article: Celgene's phase 3 AML test chalks up a win	GN	Biotech2050		9	9/16/2019 11:35:14 AM

662	Lymphoma News Today: Opdivo-Adcetris Combo Shows Promise in Advanced PMBL Patients in Trial	GN	Biotech2050		3	9/16/2019 10:05:55 AM

661	OncLive Insights: Iberdomide Shows Promise in Heavily Pretreated Multiple Myeloma	GN	Biotech2050		5	9/16/2019 7:55:24 AM

660	Endpoints article: Celgene's AML drug clears late-stage test	GN	Biotech2050		10	9/16/2019 7:45:23 AM

659	Celgene will hit another revenue inflection point after #IMW2019 congress held this weekend and great promise for the future (CC-220)	GN	Biotech2050		8	9/16/2019 3:02:39 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement